1. There is No Distinctive Gut Microbiota Signature in the Metabolic Syndrome: Contribution of Cardiovascular Disease Risk Factors and Associated Medication
   Adrián Cortés-Martín et al, 2020, Microorganisms CrossRef
2. The future of diabetic kidney disease management: what to expect from the experimental studies?
   Federica Barutta et al, 2020, J Nephrol CrossRef
3. Microbiome-Metabolome Signature of Acute Kidney Injury
   Nadezda V. Andrianova et al, 2020, Metabolites CrossRef
4. Gut Microbiota and Gestational Diabetes Mellitus: A Review of Host-Gut Microbiota Interactions and Their Therapeutic Potential
   Zubaidah Hasain et al, 2020, Front. Cell. Infect. Microbiol. CrossRef
5. Gut-Muscle AxisExists and May Affect Skeletal Muscle Adaptation to Training
   Katarzyna Przewłócka et al, 2020, Nutrients CrossRef
6. Microbiota-Derived Metabolites in Tumor Progression and Metastasis
   Tania Rossi et al, 2020, IJMS CrossRef
7. Gut Microbiota and Intestinal Trans-Epithelial Permeability
   Bénédicte Allam-Ndoul et al, 2020, IJMS CrossRef
8. Jinmaitong ameliorates diabetic peripheral neuropathy in streptozotocin-induced diabetic rats by modulating gut microbiota and neuregulin 1
   Jun Xie et al, 2020, Aging CrossRef
9. Do the Bugs in Your Gut Eat Your Memories? Relationship between Gut Microbiota and Alzheimer’s Disease
   Emily M. Borsom et al, 2020, Brain Sciences CrossRef
10. Exploring the Triple Interaction between the Host Genome, the Epigenome, and the Gut Microbiome in Type 1 Diabetes
    Duaa Ahmed Elhag et al, 2020, IJMS CrossRef
11. The role of the gut microbiome and diet in the pathogenesis of non-alcoholic fatty liver disease
    Erica Jennison et al, 2021, Clin Mol Hepatol CrossRef
12. Glatiramer acetate treatment inhibits inflammatory responses and improves survival in a mice model of cecal ligation and puncture-induced sepsis
    Elahe Maleki et al, 2021 CrossRef
13. Epigenetic Regulation of Gut Microbial Dysbiosis
    Shivani Srivastava et al, 2021, Indian J Microbiol CrossRef
14. Manipulation of intestinal microbiome as potential treatment for insulin resistance and type 2 diabetes
    Yasaman Ghorbani et al, 2021, Eur J Nutr CrossRef
15. Microbiome Composition and Function in Aquatic Vertebrates: Small Organisms Making Big Impacts on Aquatic Animal Health
    Ludek Sehnal et al, 2021, Front. Microbiol. CrossRef
16. Leaky Gut: Effect of Dietary Fiber and Fats on Microbiome and Intestinal Barrier
    Haruki Usuda et al, 2021, IJMS CrossRef
17. Bacterial-Induced Blood Pressure Reduction: Mechanisms for the Treatment of Hypertension via the Gut
    Tyler Alexander Cookson, 2021, Front. Cardiovasc. Med. CrossRef
18. High-Fat, Western-Style Diet, Systemic Inflammation, and Gut Microbiota: A Narrative Review
    Ida Judyta Malesza et al, 2021, Cells CrossRef
19. Overview of the microbiota in the gut-liver axis in viral B and C hepatitis
    Maria Adriana Neag et al, 2021, WJG CrossRef
20. Dairy Lactic Acid Bacteria and Their Potential Function in Dietetics: The Food–Gut-Health Axis
    Duygu Ağagündüz et al, 2021, Foods CrossRef
21. Dietary Supplementation with Vitamin D, Fish Oil or Resveratrol Modulates the Gut Microbiome in Inflammatory Bowel Disease
    Vivian Naa Amua Wellington et al, 2021, IJMS CrossRef
22. The Intestinal Barrier and Permeability
    Piero Portincasa et al, 2021, Biomedicines CrossRef
23. Gut Microbiome in Retina Health: The Crucial Role of the Gut-Retina Axis
    Gianluca Scuderi et al, 2022, Front. Microbiol. CrossRef
24. Gut Microbiota: An Important Player in Type 2 Diabetes Mellitus
    Zheng Zhou et al, 2022, Front. Cell. Infect. Microbiol. CrossRef
25. Profiles of gut microbiota in obese-insulin-resistant rats treated with biotics
    Sirawit Sriwichaiin et al, 2022, Eur J Nutr CrossRef
26. Compositional Alterations of Gut Microbiota in Patients with Diabetic Kidney Disease and Type 2 Diabetes Mellitus
    Xin He et al, 2022, DMSO CrossRef
27. Pathophysiological Commonality Between Irritable Bowel Syndrome and Metabolic Syndrome: Role of Corticotropin-releasing Factor–Toll-like Receptor 4–Proinflammatory Cytokine Signaling
    Tsukasa Nozu et al, 2022, J Neurogastroenterol Motil CrossRef
28. Chronic stress and captivity alter the cloacal microbiome of a wild songbird
    Anne A. Madden et al, 2022 CrossRef
29. Gut microbiota and diabetic kidney diseases: Pathogenesis and therapeutic perspectives
    Jia-Ran Lin et al, 2022, WJD CrossRef
30. The Preventive Effects of Fermented and Germinated Foxtail Millet Whole Grain on Kidney Damage in a Diabetic Mouse Model
    Xia Liu et al, 2022, Front. Nutr. CrossRef
31. The Specific Alteration of Gut Microbiota in Diabetic Kidney Diseases—A Systematic Review and Meta-Analysis
    Yuwei Wang et al, 2022, Front. Immunol. CrossRef
32. STRUCTURAL AND FUNCTIONAL INTESTINAL BARRIER ABNORMALITIES AND CHRONIC KIDNEY DISEASE. LITERATURE REVIEW. PART II
    M. O. Pyatchenkov et al, 2022, Nefrologiâ (St.-Peterbg.) CrossRef
33. Neurovascular Dysfunction in Diverse Communities With Health Disparities—Contributions to Dementia and Alzheimer’s Disease
    Napatsorn Saiyasit et al, 2022, Front. Neurosci. CrossRef
34. The Relationship Between Atrial Fibrillation and Intestinal Flora With Its Metabolites
    Dasheng Lu et al, 2022, Front. Cardiovasc. Med. CrossRef
35. Age-Related Hearing Loss: The Link between Inflammaging, Immunosenescence, and Gut Dysbiosis
    Dagmara Kociszewska et al, 2022, IJMS CrossRef
36. Alterations of the Gut Microbiota in Patients with Diabetic Nephropathy
    Lili Zhang et al, 2022, Microbiol Spectr CrossRef
37. Dysbiosis: Gut feeling
    Rekha Jalandra et al, 2022, F1000Res CrossRef
38. Altering Microbiomes with Hydroxyapatite Nanoparticles: A Metagenomic Analysis
    Vuk Uskoković et al, 2022, Materials CrossRef
39. A comprehensive map of microbial biomarkers along the gastrointestinal tract for celiac disease patients
    Juliana Estefanía Arcila-Galvis et al, 2022, Front. Microbiol. CrossRef
40. Altered Fecal Microbiome and Correlations of the Metabolome with Plasma Metabolites in Dairy Cows with Left Displaced Abomasum
    Zhengzhong Luo et al, 2022, Microbiol Spectr CrossRef
41. Intestinal Microbiota in Children with Anemia in Southern Peru through Next-Generation Sequencing Technology
    Karla Díaz-Rodríguez et al, 2022, Children CrossRef
42. Lipopolysaccharide-induced Autophagy Increases SOX2-positive Astrocytes While Decreasing Neuronal Differentiation in the Adult Hippocampus
    Wen-Chung Liu et al, 2022, Exp Neurobiol CrossRef
43. Specific alterations of gut microbiota in diabetic microvascular complications: A systematic review and meta-analysis
    Jinni Hong et al, 2022, Front. Endocrinol. CrossRef
44. Exploring the Relevance between Gut Microbiota-Metabolites Profile and Chronic Kidney Disease with Distinct Pathogenic Factor
    Tso-Hsiao Chen et al, 2022, Microbiol Spectr CrossRef
45. The role and mechanism of gut microbiota-derived short-chain fatty in the prevention and treatment of diabetic kidney disease
    Pengyu Tao et al, 2022, Front. Immunol. CrossRef
46. Gut bacterial species in late trimester of pregnant sows influence the occurrence of stillborn piglet through pro-inflammation response
    Zhe Chen et al, 2023, Front. Immunol. CrossRef
47. Effects of a probiotic suspension Symprove™ on a rat early-stage Parkinson’s disease model
    Marco Sancandi et al, 2023, Front. Aging Neurosci. CrossRef
48. Intestinal microbiome diversity of diabetic and non-diabetic kidney disease: Current status and future perspective
    Soumik Das et al, 2023, Life Sciences CrossRef
49. Gut microbiota and its metabolites – molecular mechanisms and management strategies in diabetic kidney disease
    Zi-Hui Mao et al, 2023, Front. Immunol. CrossRef
50. Chlorella modulation of gut microbiota dysbiosis in patients with type-2 diabetes
    Fernanda Martins et al, 2023, Fundam. Toxicol. Sci. CrossRef
51. Slowed gastrointestinal transit is associated with an altered caecal microbiota in an aged rat model
    Nabil Parkar et al, 2023, Front. Cell. Infect. Microbiol. CrossRef
52. Association between salivary microbiota and renal function in renal transplant patients during the perioperative period
    Xuyu Xiang et al, 2023, Front. Microbiol. CrossRef
53. null
    Alexandru Stefan Barcan et al, 2023 CrossRef
54. Gut microbiota composition and function in pregnancy as determinants of prediabetes at two-year postpartum
    Noora Houttu et al, 2023, Acta Diabetol CrossRef
55. Fecal metabolomics combined with 16S rRNA gene sequencing to analyze the effect of Jiaotai pill intervention in type 2 diabetes mellitus rats
    Jing Liu et al, 2023, Front. Nutr. CrossRef
56. The role of gut microbiota in diabetic peripheral neuropathy rats with cognitive dysfunction
    Wei Huang et al, 2023, Front. Microbiol. CrossRef
57. Bibliometric visualization analysis of gut-kidney axis from 2003 to 2022
    Sinan Ai et al, 2023, Front. Physiol. CrossRef
58. The Intestinal Microbiota Composition in Early and Late Stages of Diabetic Kidney Disease
    Li Zhang et al, 2023, Microbiol Spectr CrossRef
59. The pathogenic role of intestinal flora metabolites in diabetic nephropathy
    En Tian et al, 2023, Front. Physiol. CrossRef
60. The roles of gut microbiota and its metabolites in diabetic nephropathy
    Hui Zhao et al, 2023, Front. Microbiol. CrossRef
61. Jiangtang Decoction Ameliorates Diabetic Kidney Disease Through the Modulation of the Gut Microbiota
    Jinni Hong et al, 2023, DMSO CrossRef
62. HIV and Aging: HIV seen as a Chronic Inflammatory Intestinal Disease.
    Martin L. Gnoni, 2023 CrossRef
63. The Role of Type 2 Diabetes Mellitus–Related Risk Factors and Drugs in Hepatocellular Carcinoma
    Yuhua Mai et al, 2024, JHC CrossRef
64. Research Progress in the Treatment of Diabetic Nephropathy Based on Intestinal Microecology
    新建 纪, 2024, HJBM CrossRef
65. Fecal Microbiota Transplantation: A Prospective Treatment for Type 2 Diabetes Mellitus
    Xiaolan Zhou et al, 2024, DMSO CrossRef
66. Effects of Black Quinoa Polysaccharides on Obesity and Intestinal Flora Dysbiosis in T2DM Mice
    Yanqing Zang et al, 2024, Journal of Food Biochemistry CrossRef
67. Assessing the causal relationship between gut microbiota and diabetic nephropathy: insights from two-sample Mendelian randomization
    Yipeng Fang et al, 2024, Front. Endocrinol. CrossRef
68. Deep metagenomic characterization of the gut virome in pregnant women with preeclampsia
    Li-Juan Lv et al, 2024, mSphere CrossRef
69. Association between gut microbiota and diabetic nephropathy: a mendelian randomization study
    Yongxiu Jin et al, 2024, Front. Microbiol. CrossRef
70. Research progress on the mechanism of TCM regulating intestinal microbiota in the treatment of DM mellitus
    Yang Ping et al, 2024, Front. Endocrinol. CrossRef
71. Specific Alternation of Gut Microbiota and the Role of Ruminococcus gnavus in the Development of Diabetic Nephropathy
    Jinni Hong et al, 2024, J. Microbiol. Biotechnol. CrossRef